Scientists at St. Jude Children’s Research Hospital have created an extensive map of NUDT15 variants to more accurately predict toxicity from the critical cancer drugs thiopurines.
Scientists at St. Jude Children’s Research Hospital have implicated two microRNAs in the biological processes that underlie the ventricle enlargement observed in models of schizophrenia.
By identifying these models, St. Jude researchers believe that they can predict liquid-liquid phase separation, which is an important activity for cells. Learn more.
The Pediatric Cancer Genome Project marks a decade of discovery that has advanced understanding, diagnosis and treatment of childhood cancer.
Results show a gene that drives cancer by promoting alternative polyadenylation
Findings from a collaborative clinical trial have generated key insights into how targeted therapy should be used to treat leukemia driven by the Philadelphia chromosome.
Akshay Sharma, MBBS, of St. Jude is the recipient of a 2020 Scholar Award from the American Society of Hematology (ASH).
The new Shared Resource Center will enhance the capabilities of St. Jude researchers looking to discover new treatments for pediatric cancer.
St. Jude Children’s Research Hospital scientists have identified proteins that play critical roles in Alzheimer’s disease and provide a framework for developing new diagnostic and treatment strategies.
Scientists explain how cell death caused from this protein could lead to drug treatments to prevent the inflammatory, cell-killing response of septic shock.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.